C&D personal care sales up
This article was originally published in The Rose Sheet
Executive Summary
Net sales in the firm's personal care segment rose 10.1% in first quarter 2009 (ended March 27), to $154 mil., largely on the entry of new products, Church & Dwight says in a May 5 earnings call. Personal care sales growth was slowed by the timing of new product launches, including SpinBrush Sonic toothbrushes and two Baby Orajel oral care products. Chairman and CEO James Craigie has said C&D is actively seeking personal care brand acquisitions (1"The Rose Sheet" Feb. 9, 2009, p. 6). Net revenues grew 5.1% to $580.9 mil. over the year-ago period and net income for the Princeton, N.J.-based consumer products company increased 11.4% to $62.6 mil. C&D estimates its full-year EPS at $3.30-$3.35, a 15% to 17% increase over fiscal 2008 results
You may also be interested in...
Have A Brand For Sale? Church & Dwight Hungry For Acquisitions In Lean Times
Church & Dwight is actively pursuing brand acquisitions in the personal-care and household-care sectors, optimistic that a scarcity of bidders at the moment will ensure an attractive buying price
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.